Press Releases
Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine
Verona Pharma plc , a biopharmaceutical company focused on respiratory diseases, announces two senior appointments to its clinical team. They will lead the Phase 3 program for Verona Pharma’s first-in-class product candidate, ensifentrine, for the maintenance treatment of chronic...
IT & Data Management
The Medison network of clinics Tbilisi Georgia joins Clinerions Patient Network Explorer platform bringing their patients accelerated access to next generation treatments and therapies
The Medison network of clinics specializes in outpatient and dental services for all social strata, focusing on patient health care, disease prevention, and timely and correct diagnosis. The four clinics in Tbilisi, Georgia, provide medical care to over 6,000...
Packaging & Labelling
Singapore Airlines Cargo Broadens Range Of Solutions For Pharmaceutical Cargo
Patients at Medison’s network of clinics will gain access to next generation treatments and therapies by being matched to leading-edge, international clinical trials. This will also accelerate the launch of new treatments and medications in Georgia.
The Medison network of...
Packaging & Labelling
Pharmaceutical packaging: Advantages of digital printing technology in blister packaging
Producing pharmaceutical products for the global market is hugely challenging and complex.
When a drug is set to be sold in multiple countries, it needs to be packaged in a way which accommodates the regulatory requirements and specific artwork demands...
Drug Research
Pathogen engineered to self destruct underlies cancer vaccine platform
A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-destruct once they've done their job, making it safe for use in humans. The...
Drug Research
Artificial DNA can control release of active ingredients from drugs
A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist's dream is now much closer to...
Clinical Trials
SpringWorks and GSK sign clinical trial collaboration agreement
SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma.
Under the clinical trial collaboration agreement, GSK will sponsor and conduct an adaptive Phase...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read